Home Journals Articles Updates About
CN
image
收藏切换
Progress and prospect in the clinical translation of cancer nanomedicine
收藏切换
PDF
Zhao-hui WANG, Yu-ling LIU*
Acta Pharmaceutica Sinica | 2022, 57(1) : 134 - 141
Less
收藏切换
Acta Pharmaceutica Sinica | 2022, 57(1): 134-141
• Reviews •
Progress and prospect in the clinical translation of cancer nanomedicine
Full
Zhao-hui WANG, Yu-ling LIU*
Affiliations
  • State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
Published: 2022-01-12 doi: 10.16438/j.0513-4870.2021-1259
Outline
收藏切换

Nanotechnology has shown broad application prospects in the diagnosis and treatment of cancer. Currently, nearly 80 cancer nanomedicines are under clinical investigation, and many have been approved with enhanced anti-tumor efficacy and decreased side effects. However, the presence of various barriers in related basic research, process control and clinical trials lead to extremely low translation rate. From the perspective of clinical commercialization, we summarized the progress, clinical status, challenges and opportunities of cancer nanomedicine, and presented a cutting-edge prospect on the rational design of nanomedicine and clinical trial strategies.

tumor therapy  /  nanomedicine  /  targeted therapy  /  clinical translation  /  patient stratification  /  biomarker
Zhao-hui WANG, Yu-ling LIU. Progress and prospect in the clinical translation of cancer nanomedicine[J]. Acta Pharmaceutica Sinica, 2022 , 57 (1) : 134 -141 . DOI: 10.16438/j.0513-4870.2021-1259
Appendix
Less
Year 2022 volume 57 Issue 1
PDF
247
105
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2021-1259
  • Receive Date：2021-08-30
  • Online Date：2025-12-22
  • Published：2022-01-12
Article Data
Affiliations
History
  • Received：2021-08-30
  • Revised：2021-09-28
Funding
Affiliations
    State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing Key Laboratory of Drug Delivery Technology and Novel Formulation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2021-1259
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family		 属数
Number of
genus		 种数
Number of
species		 占总种数比例
Percentage of
total species (%)		 属
Genus		 种数
Number of
species		 占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT
Links
Articles
Latest Articles
Most Read
Collections
Updates
Events
News
Multimedia
About
About Us
Contact
No. 86 Xueyuan South Road, Haidian District, Beijing
100081
010-62199257
qkjq@cast.org.cn

Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House